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J. Horn,* A.R. Naylor, D.M. Laman, B.R. Chambers, J.L. Stork, T.V. Schroeder,
M.-Y. Nielsen, V.G. Dunne and R.G.A. AckerstaffDepartment of Clinical Neurophysiology, Antonius Hospital, P.O. Box 2500, 3430 EM Nieuwegein,
The NetherlandsObjectives. Transcranial Doppler (TCD) monitoring for micro embolic signals (MES), directly after carotid
endarterectomy (CEA) may identify patients at risk of developing ischaemic complications. In this retrospective multicentre
study, this hypothesis was investigated.
Methods. Centres that monitored for MES after CEA were identified by searching Medline. Individual patient data were
obtained from centres willing to collaborate. The number of emboli in 1 h was computed. Uni- and multivariate logistic
regression analyses were performed for the variables gender, age and number of MES. Discriminative ability of MES
monitoring was investigated in a ROC curve.
Results. Nine hundred and ninety-one patients were monitored in the first 3 h after CEA. Two percent developed ischaemic
cerebral complications. Univariate analysis revealed statistically significant associations between ischaemic cerebral
complications and both gender and MES, but not age. In a multivariate analysis, R8 MES/h showed a statistically
significant relationship with cerebral complications (OR 8.1, 95% CI 1.8–36), in contrast to gender (OR 2.2, 95% CI 0.9–
5.5). The ROC curve yielded an AUC of 0.83 for monitoring of MES.
Conclusions. These results support the use of TCD monitoring for MES shortly after CEA in order to identify patients at
risk of developing ischaemic cerebral complications.Keywords: Carotid endarterectomy; TCD; Embolism.Introduction
Several large randomised trials have shown that
patients with both symptomatic and asymptomatic
stenosis of the carotid artery may benefit from carotid
endarterectomy (CEA).1–3 Themost important surgical
complication remains ipsilateral ischaemic stroke,
which usually develops during or shortly after CEA.
Whereas cerebral ischaemia developing during CEA
has been considered to be directly related to surgical
techniques, the post surgical ischaemic complications
have been found to be mainly of thromboembolic
origin.4ing author. Janneke Horn, Department of Clinical
logy, Antonius Hospital, P.O. Box 2500, 3430 EM
The Netherlands.
: jhorn@planet.nl
0270+ 05 $35.00/0 q 2005 Elsevier Ltd. All rights reserSeveral studies have suggested that transcranial
Doppler (TCD)monitoring directly after surgery could
identify patients at risk of developing ischaemic
complications.5–8 In patients who developed cerebral
ischaemic complications, more micro embolic signals
(MES) were detected in the middle cerebral artery
ipsilateral to the operated carotid artery, compared to
patients without such complications. However, most
of these studies were underpowered, because the
number of patients was relatively small and the
number of ischaemic cerebral complications was
limited.
The aim of this retrospective multicentre study
was to investigate whether MES monitoring shortly
after surgery could identify patients at risk for
ischaemic cerebral complications after carotid
endarterectomy.Eur J Vasc Endovasc Surg 30, 270–274 (2005)
doi:10.1016/j.ejvs.2005.04.033, available online at http://www.sciencedirect.com onved.
TCD Monitoring After Carotid Endarterectomy 271MethodsData collection
By searching Medline (last searchMay 2004), using the
search terms: ‘TCD’ (ultrasonography, Doppler, tran-
scranial; cerebrovascular circulation, or cerebral
arteries, or brain), ‘carotid endarterectomy’ and
‘embolism’ (air embolism, or intracranial embolism,
or intracranial embolism and thrombosis), centres that
monitor MES after CEAwere identified. Reference lists
of identified manuscripts were also searched for
additional documents and centres, and authors of
manuscripts were asked whether they were aware of
any other (unpublished) studies, or centres monitoring
MES after CEA. All identified centres were invited to
join this collaborative research project and to share
individual patient data.
We used the definition of MES, which has been
established by two consensus committees.9,10 Accord-
ing to these definitions a MES must always have the
following characteristics: (1) its signal is transient,
usually lasting less than 300 ms, (2) its amplitude is
usually at least 3 dB higher than that of the back-
ground blood flow signals, (3) its signal is uni-
directional within the Doppler velocity spectrum,
and (4) a MES is accompanied by a ‘snap’, ‘chirp’, or
‘moan’ on the audible output.
All CEA patients, in whom transcranial Doppler of
the ipsilateral middle cerebral artery was performed
within 1 day after surgery were included in the study.
Patients with new neurological deficits at the end of
the surgical procedure, and patients with an intracra-
nial haemorrhage were excluded (for example as a
result of a hyperperfusion syndrome).
Outcome measures: cerebral ischaemic compli-
cations, defined as new neurological deficits
(amaurosis fugax, TIA, minor and major ischaemic
stroke) developing within the 1st week after CEA.
The following data was collected: age, gender,
number of micro emboli, ischaemic cerebral compli-
cations, hospital protocols regarding medication
before, during and after CEA, and method of emboli
monitoring (time interval between the end of the
surgical procedure and the start of monitoring,
duration of monitoring, method of emboli registration,
technical details of monitoring).Analyses and statistical methods
As the duration of monitoring differed between the
collaborating centres, we recomputed data to number
of emboli in 60 min for each patient. These figureswere divided into tertiles (0, 1–7 and R8 MES/h) for
further analyses. A univariate logistic regression
analysis was performed for the variables gender, age
and number of MES in 1 h. Multivariate logistic
regression analyses were then undertaken, including
only statistically significant factors from the univariate
analysis (gender and number of MES). The associ-
ations were expressed with odds ratios (OR) as effect
estimates, and 95% confidence intervals (CI) to
describe the precision of the estimates. To investigate
the discriminative ability of MES monitoring and to
determine the optimal cut-off value, a ROC curve was
constructed, plotting sensitivity versus ‘one minus
specificity’ for all possible cut-off values.11Results
Ten centres where patients were monitored for emboli
after carotid endarterectomy were identified and
invited to join this collaboration.5,7,8,12–17 Although
all centres were willing to join, individual patient data
were received from seven centres (Table 1). Each centre
used different methods of monitoring, especially with
respect to time intervals between start of recirculation
or end of surgery and start of monitoring, duration of
monitoring, and use of anti-platelet medication before
and after surgery. From the centre in Rome, we
received data of 14 patients all of whom developed
neurological complications during (nZ11) or after (nZ
3) surgery.14 As we did not receive data of patients
who did not develop neurological complications, we
had to exclude these data from further analyses. The
patients from the hospital in Melbourne (nZ139) were
participants in a randomised, double-blind placebo-
controlled study examining the effect of Dextran
therapy on the number of MES and the functional
outcome after CEA.13 As the last part of this study was
still ongoing, we received data ‘blinded’ with regard to
treatment group. Data of 1047 patients were available
for analysis, 991 patients were monitored in the first
3 h after surgery, and in 56 monitoring started the day
after surgery (Copenhagen). As we were primarily
interested in the relationship between MES shortly
after surgery and ischaemic cerebral complications,
the latter were excluded from the logistic regression
analysis.
In the group of 991 patients, 19 (2%) developed an
ischaemic cerebral complication. The available data
did not allow us to distinguish between transient
ischaemic attacks and minor or major ischaemic
strokes. The results of the logistic regression analyses
are shown in Table 2. In the univariate regression
analysis, female gender and R8 MES/h showedEur J Vasc Endovasc Surg Vol 30, September 2005
Table 1. Methodology of monitoring of MES in the collaborating centres
Center No. of
patients
Time interval
surgery—
insonation
Duration
(min)
Method of emboli
quantification
Medication (before, during and after
CEA)
Leicester5 510 3 h 180 Personal counting Aspirin 75 mg daily, heparin 5000 IU,
dextran*
Amsterdam15 166 Median 30 min 10–20 Personal counting Oral anticoagulants†, heparin 5000 IU,
aspirin bolus‡
Melbourne13 139 0–1, 2–3, 4–6 h 30 Personal counting Aspirin, heparin, randomisation for
dextran
Nieuwegein32 126 2nd hour post CEA 60 Computer algorithm,
checked if necessary
Aspirin 100 mg daily, heparin 5000 IU,
dextran§
Copenhagen17 56 1 day, 2/3rd day,
5th day
45 Personal and
computer algorithm
Heparin 3500 IU, aspirin 100–150 mg
daily after discharge
Sydney7 50 1 h (after flow
restoration), 1 day
20 Personal counting Aspirin 150 mg daily, heparin 5000 IU,
dextran¶
Rome14,s 30 min (after flow
restoration), 1 day
30 Computer algorithm
and personal
Aspirin, ticlopidine until surgery, and
heparin 5000 IU
* Dextran-40 (20 ml/h, increased by 5 ml/h until embolisation diminished, this dose was continued for 12 h) administered to patients with
O25 emboli in a 10 min period, or when emboli distorted the MCAwaveform, suggesting large size.
† Oral anticoagulants were started before surgery, aspirin was stopped 8 days before surgery.
‡ In case of multiple MES during monitoring 500 mg aspirin was administered.
§ Dextran administered at discretion of the surgeon.
¶ Dextran-40 (125 ml/h for 4 h, 42 ml/h for ensuing 12 h) when embolic load O50/h.
s Excluded from analysis.
J. Horn et al.272statistically significant associations with ischaemic
cerebral complications after surgery. There was no
statistically significant association for age or small
numbers of MES (first and second tertile).
In the multivariate analysis, the only statistically
significant independent predictor wasR8 MES/h (OR
8.1, 95% CI 1.8–36.0). There was a non-significant trend
for female gender (OR 2.2, 95% CI 0.9–5.5). An
additional multivariate logistic regression analysis in
which the first and second tertiles of number of MES
were combined (0–7 MES), compared to patients in the
third tertile (R8 MES), yielded similar results for the
latter group (OR 10.0, 95% CI 2.9–34.7).
The ROC curve of MES monitoring (Fig. 1) yielded
an area under the curve of 0.83 (95% CI 0.71–0.94). The
highest specificity and sensitivity were found for 14
MES in 1 h, respectively, 76 and 84%. Other cut-off
values of MES, with the corresponding specificity and
sensitivity are given in Table 3.Table 2. Results of univariate and multivariate regression analyses
Variable Complication Univariate
K C Odds ratio
All 972 19
Male 702 9
Female 270 10 2.9
MES 0 364 2
MES 1–7 292 1 0.6
MESR8 316 16 9.2
Age!75 807 16
AgeR75 165 3 1.0†
NI, not included in multivariate logistic regression analysis.
* Result of multivariate regression analyses when first two tertiles of
† For the univariate logistic regression analysis of age a categorical m
Eur J Vasc Endovasc Surg Vol 30, September 2005Discussion
Carotid endarterectomy is probably one of the best
investigated surgical procedures performed,18,19 and
in order to minimize the risk of an ischaemic stroke
during or shortly after surgery, both surgical strat-
egies17,20–22 and monitoring strategies6,7,14 have been
developed. Implementation of the results of the MRC
Asymptomatic Carotid Surgery Trial may lead to an
increase in the number of CEAs performed.2 As the
authors of the manuscript emphasize: ‘The balance of
risk and benefit depends on surgical morbidity rates
and on the risk of carotid stroke in the absence of
surgery’. Therefore, strategies to diminish the number
of complications seem are of utmost importance.
In this study, we found an overall 2% risk of
developing cerebral ischaemic complications shortly
after successful surgery. Compared to other CEA
studies this number of complications is small, butMultivariate
95% CI Odds ratio 95% CI
1.2–7.2 2.2, 2.2* 0.9–5.5, 0.9–5.5*
0.06–6.9 0.6 0.05–6.6
2.1–40.4 8.1, 10.0* 1.8–36.0, 2.9–34.7*
0.9–1.1 NI
MES were combined.
ethod was used.
Fig. 1. Diagonal segments are produced by ties.
TCD Monitoring After Carotid Endarterectomy 273hemorrhagic complications and patients who were
found to have neurological deficits directly after
surgery were excluded.1,3,23
The role of MES in identifying patients at risk of
developing ischaemic cerebral complications several
hours after surgeryhas been investigated extensively.6,24
With the results of this systematic review, in which
data of almost 1000 patients were included, we add
further support to the hypothesis that TCDmonitoring
for MES shortly after CEA can identify patients at risk
of developing cerebral ischaemic complications. A
statistically significant relationship was found when
O8 MES in 1 h were detected. However, because the
number of patients experiencing cerebral ischaemic
complications shortly after surgery is small, the
confidence interval is large, making it difficult to
come to a firm conclusion. The ROC curve shows that
TCD monitoring for MES has good discriminative
properties. At a cut-off value of 14 MES in 1 h, the best
combination of specificity and sensitivity, respectively,
76 and 84%, are found for this diagnostic test.Table 3. Cut-off values of MES
Emboli in 1 h Sensitivity (%) Specificity (%)
0.5 90 37
8 84 69
14 84 76
25 63 85
38 58 90Depending on clinical circumstances, physicians
should decide whether this sensitivity and specificity
is acceptable. A false negative rate of 16% can be
judged too high depending on many factors, making
it acceptable to choose a sensitivity of 90%, accepting
a specificity of 37%. This could hypothetically
mean that 73% of patients would receive harmful
treatment.
Monitoring for MES itself will not be able to
improve the results of CEA, but a proper quantitative
diagnostic tool will help in deciding which patients
could benefit from additional treatment. Several drugs
with the potential to decrease the number of MES have
been trialled.12,25–27
In contrast to other studies, we did not find a
significantly higher risk of complications after CEA in
females.15,24,28–30 Other baseline characteristics, which
could possibly be risk factors, such as diabetes,
hypertension and peripheral vascular disease, were
not analysed in this review as we were unable to
retrieve these data from all the collaborating centres.
The methodology of this study has disadvantages and
the results should be interpreted cautiously. We may
not have identified all centres, which monitor MES
after carotid surgery: it is likely that small series of
patients remain unpublished and have therefore
escaped our attention. The outcome measure used in
this analysis, cerebral ischaemic complications, was
not ideal. Functional outcome several months after
surgery would probably have allowed a more clini-
cally useful assessment for the practicing clinician.
These data would be essential for a cost-benefit
analysis of this diagnostic test. Finally, we also lacked
information about who performed the neurological
assessment of patients after surgery. It may be that this
was not assessed by suitably qualified clinicians in all
collaborating centres, which may have led to an
underestimation of the number of cerebral compli-
cations.31 Ideally, a randomised controlled trial to
validate this diagnostic tool should be performed, but
such a study would have to include a large number of
patients. An international multi-centre study would be
needed.
This study shows that monitoring of MES after CEA
can be helpful in the identification of patients at risk of
cerebral ischaemic complications. However, as moni-
toring of MES is expensive and the risk of developing
cerebral ischaemic complications after the surgical
procedure is low, monitoring of all patients after CEA
is impractical. For the future it seems crucial to
identify risk factors for post-CEA ischaemic compli-
cations before surgery, so monitoring can be per-
formed in this targeted sub-group.Eur J Vasc Endovasc Surg Vol 30, September 2005
J. Horn et al.274Acknowledgements
We would like to thank Dr A. Algra, Clinical Epidemiologist
at the University Medical Center Utrecht, for help with the
data analyses. For contributions of various sorts go to M.
Besser (Sydney), W.J. Ma (Sydney), M. van der Mee
(Nieuwegein), I. vd Schaaf (Nieuwegein).References
1 European Carotid Surgery Trialists’ Collaborative Group. Ran-
domised trial of endarterectomy for recently symptomatic
carotid stenosis: final results of the MRC European Carotid
Surgery Trial (ECST). Lancet 1998;351:1379–1387.
2 MRC Asymptomatic Carotid Surgery Trial Collaborative Group.
Prevention of disabling and fatal strokes by successful carotid
endarterectomy in patients without recent neurological symp-
toms: randomised controlled trial. Lancet 2004;363:1491–1502.
3 North American Symptomatic Carotid Endarterectomy Trial
Collaborators. The final results of the NASCET trial.N Engl J Med
1998;339:1415–1425.
4 Riles TS, Imparato AM, Jocbowitz GR, Lamparello PJ,
Giangola G, Adelman MA et al. The cause of perioperative
stroke after carotid endarterectomy. J Vasc Surg 1994;19:206–216.
5 Naylor AR, Hayes PD, Allroggen H, Lennard N, GauntME,
Thompson MM et al. Reducing the risk of carotid surgery: a 7-
year audit of the role of monitoring and quality control
assessment. J Vasc Surg 2000;32:750–759.
6 Lennard N, Smith JL, Dumville J, Abbott RJ, Evans DH,
LondonNJM et al. Prevention of postoperative thrombotic stroke
after carotid endarterectomy: the role of transcranial Doppler
ultrasound. J Vasc Surg 1997;26:579–584.
7 Levi CR, O’Malley HM, Fell G, Roberts AK, Hoare MC,
Royle JP et al. Transcranial Doppler detected cerebral micro-
embolism following carotid endarterectomy. High microembolic
signal loads predict postoperative cerebral ischaemia. Brain 1997;
120:621–629.
8 Cantelmo NL, Babikian VL, Samaraweera RN, Gordon JK,
Pochay VE, Winter MR. Cerebral microembolism and ischemic
changes associated with carotid endarterectomy. J Vasc Surg 1998;
27:1024–1031.
9 Ringelstein EB, Droste DW, Babikian VL, Evans DH,
Grosset DG, Kaps M et al. Consensus on microembolus
detection by TCD. Stroke 1998;29:725–729.
10 Consensus Committee of the Ninth International Cerebral
Hemodynamic Symposium. Basic identification criteria of
Doppler microembolic signals. Stroke 1995;26:1123.
11 Weinstein MC, Fineberg HV. Clinical decision analysis. Philadel-
phia, W.B. Saunders Company, 1980.
12 Kaposzta Z, Baskerville PA, Madge D, Fraser SCA,
Martin JF, Markus HS. L-Arginine and S-nitrosoglutathione
reduce embolization in humans. Circulation 2001;103:2371–2375.
13 Dunne VG, Besser M, Wen JM. Transcranial Doppler in carotid
endarterectomy. J Clin Neurosci 2001;8:140–145.
14 Gossetti B,MartinelliO,Guerricchio R, Irace L, Benedetti-
Valentini F. Transcranial Doppler in 178 patients before, during,
and after carotid endarterectomy. J Neuroimaging 1997;7:213–216.
15 Laman DM, Wieneke GH, van Duijn H, van Huffelen AC.
High embolic rate early after carotid endarterectomy isEur J Vasc Endovasc Surg Vol 30, September 2005associated with early cerebrovascular complications, especially
in women. J Vasc Surg 2002;36:278–284.
16 Spencer MP. Transcranial Doppler monitoring and causes of
stroke from carotid endarterectomy. Stroke 1997;28:685–691.
17 GaoM-Y, SillesenHH, Lorentzen JE, Schroeder TV. Eversion
carotid endarterectomy generates fewer microemboli than
standard carotid endarterectomy. Eur J Vasc Endovasc Surg 2000;
20:153–157.
18 Cina CS, Clase CM, Haynes RB, Carotid endarterectomy for
symptomatic stenosis (Cochrane review) The Cochrane library 2002.
19 Chambers BR, You RX, Donnan GA, Carotid endarterectomy for
asymptomatic carotid stenosis (Cochrane review) The Cochrane library
2002.
20 Bond R, Rerkasem K, Counsell C, Salinas R, Naylor AR,
Warlow CP et al, Routine or selective carotid artery shunting
for carotid endarterectomy (Cochrane review) The Cochrane library
2002.
21 Counsell C, Salinas R, Warlow CP, Naylor AR, Patch
angioplasty versus primary closure for carotid endarterectomy
(Cochrane review) The Cochrane library 2002.
22 Hayes PD, Allroggen H, Steel S, Thompson MM,
London NJM, Bell PRF et al. Randomized trial of vein versus
Dacron patching during carotid endarterectomy: Influence of
patch type on postoperative embolization. J Vasc Surg 2001;
33:994–1000.
23 Ferguson GG, Eliasziw M, Barr HWK, Clagett GP,
Barnes RW, Wallace MC et al. The North American Sympto-
matic Carotid Endarterectomy Trial. Surgical results of 1415
patients. Stroke 1999;30:1751–1758.
24 Stork JL, Levi CR, Chambers BR, Abbott AL, Donnan GA.
Possible determinants of early microembolism after carotid
endarterectomy. Stroke 2002;33:2082–2085.
25 Levi CR, Stork JL, Chambers BR, Abbott AL, Cameron HM,
Peeters A et al. Dextran reduces embolic signals after carotid
endarterectomy. Ann Neurol 2001;50:544–547.
26 Payne D, Jones CI, Hayes PD, Thompson MM, London NJM,
Bell PRF et al. Beneficial effects of clopidogrel combined with
aspirin in reducing cerebral emboli in patients undergoing
carotid endareterctomy. Circulation 2004;109:1476–1481.
27 Hayes PD, Lloyd AJ, Lennard N, Wolstenholme JL,
London NJM, Bell PRF et al. Transcranial Doppler-directed
Dextran-40 therapy is a cost-effective method of preventing
carotid thrombosis after carotid endarterectomy. Eur J Vasc
Endovasc Surg 2000;19:56–61.
28 Hayes PD, Payne D, Evans NJ, Thompson MM, London NJM,
Bell PRF et al. The excess of strokes in female patients after CEA
is due to their increased thromboembolic potential-analysis of
775 cases. Eur J Vasc Endovasc Surg 2003;26:665–669.
29 Sarac TP, Hertzer NR, Mascha EJ, O’Hara PJ, Krajewski LP,
Clair DG et al. Gender as a primary predictor of outcome after
carotid endarterectomy. J Vasc Surg 2002;35:748–753.
30 Rothwell PM, Slattery J, Warlow CP. Clinical and angio-
graphic predictors of stroke and death from carotid endarter-
ectomy: systematic review. BMJ 1997;315:1571–1577.
31 Rothwell PM, Warlow CP. Is self-audit reliable? Lancet 1995;
346:1623.
32 van der Schaaf IC, Horn J, Moll FL, Ackerstaff RGA.
Transcranial Doppler monitoring after carotid endarterectomy.
Ann Vasc Surg 2005;19:19–24.
Accepted 5 April 2005
Available online 15 June 2005
